An effective vaccine against COVID-19 is need of the hour. India has been a hub for vaccine productions and Indian pharmaceutical companies have contributed immensely to the vaccine related projects running all over the world. Indian companies have also been pioneers in starting working on COVID-...
A total of 1,166,090 vaccine doses were given on Wednesday alone. Presently the third phase of COVID-19 vaccination is going on, covering all people aged 18 years and above. However, an acute shortage of vaccines is being felt across the country. Meanwhile, the federal government has ramp...
A medical worker inoculates a dose of COVID-19 vaccine to a woman at a drive-in vaccination site in Noida, India, on May 17, 2021. (Xinhua/Partha Sarkar)
COVID-19 cases in Indian states 2023, by type Medical Technology Cumulative vaccine doses administered for COVID-19 India 2021-2023 Recommended statistics Global overview Numbers in India State figures Second wave Public opinionKey insights Number of confirmed cases as of March 30, 2023 Number ...
A locally developed, but still unnamed, COVID-19 vaccine of BE has also been given regulatory approval for clinical trials in India. Details of the drug trials have not yet been disclosed. Sputnik V by Dr. Reddy’s Laboratories Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vacci...
内容提要:根据国内外大量的、充分的事实,我们确认,新冠益喵(COVID-19益喵)对人类有八大危害。COVID-19益喵是慢性基因毒药,对人类的危害比新冠病毒危害更大。新冠益喵已经和正在对全人类产生巨大灾难。 关键词:COVID-19 基因毒药 FDA CDC 从今年三月份起,我国(包括港澳台)的新冠疫情已经结束了,经济社会发展和...
A COVID-19 vaccine designed to be inexpensive and easy to mass produce globally has received emergency use authorization from India’s government,
[8] RAIR Foundation Editor, Bombshell: Nobel Prize Winner Reveals - Covid Vaccine is “Creating Variants”, May 18, 2021. Link: https://rairfoundation.com/bombshell-nobel-prize-winner-reveals-covid-vaccine-is-creating-variants/ [9] An Editor, Nobel Prize Winner French Virologist Luc ...
COVID-19 vaccine roll-out:India has released information on its vaccination program. The COVID-19 vaccine will be first administered to healthcare workers, frontline workers, and persons above the age of 50 to be followed by those younger than 50 years suffering from co-morbidities. The person...
In October 2021, Russia's Health Ministry allowed early trials of a nasal form of Sputnik V among 500 volunteers, but the status of those trials and the availability of the vaccine remains unclear. Vaccination rates in India have dipped in the past months with detected cases plateauin...